drugset / Trial / NCT03354338

Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy

NCT03354338

Phase 2 Unknown 90 enrolled Universidad El Bosque, Bogotá
RandomizedParallel-groupQuadruple-blindTreatment

Summary

There are not published studies evaluating the incidence, nature, magnitude and/or duration of bacteremia after periodontal treatment. The pre-surgical antibiotics have been studied particullary over Gram positive bacterial but not over gram negative bacterial and their secondary effects over the systemic pro-inflamation. Objective: to evaluate the efficacy of intensive periodontal therapy and pre-medication with oral amoxicilline on inflammatory bio-markers and the incidence, duration and magnitude of bacteremia in patients with chronic periodontitis.

Timeline

Start
2017-09-21
Primary completion
2018-04-30
Completion
2018-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 2 g Oral